Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary T Ferguson

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Respiratory Medicine|March 1, 2011
Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence?Gary T Ferguson
Proceedings of the American Thoracic Society|March 28, 2006
Why does the lung hyperinflate?Gary T Ferguson
Expert Review of Respiratory Medicine|May 19, 2018
An overview of glycopyrrolate/eFlow® CS in COPDEdward Kerwin, Gary T Ferguson
Postgraduate Medicine|July 5, 2018
Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary diseaseGary T Ferguson, Richard N Dalby
Pharmacoeconomics - Open|June 20, 2020
Real-World Evidence: Bridging Gaps in Evidence to Guide Payer DecisionsMelissa H Roberts, Gary T Ferguson
Respiratory Research|May 9, 2013
Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseDonald P Tashkin, Gary T Ferguson
Respiratory Medicine|February 8, 2018
Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseasesGary T Ferguson, Anthony J Hickey, Sarvajna Dwivedi
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk FactorsGary T Ferguson, Robert Tosiello, Shahin Sanjar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 10, 2013
COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled studyGary T Ferguson, Mo Ghafouri, Luyan Dai, et al.
Cureus|July 10, 2020
Spontaneous Pneumomediastinum/Pneumothorax in Patients With COVID-19Bianka Eperjesiova, Eric Hart, Mohamed Shokr, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Respiratory Medicine|March 1, 2011
Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence?Gary T Ferguson
Proceedings of the American Thoracic Society|March 28, 2006
Why does the lung hyperinflate?Gary T Ferguson
Expert Review of Respiratory Medicine|May 19, 2018
An overview of glycopyrrolate/eFlow® CS in COPDEdward Kerwin, Gary T Ferguson
Postgraduate Medicine|July 5, 2018
Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary diseaseGary T Ferguson, Richard N Dalby
Pharmacoeconomics - Open|June 20, 2020
Real-World Evidence: Bridging Gaps in Evidence to Guide Payer DecisionsMelissa H Roberts, Gary T Ferguson
Respiratory Research|May 9, 2013
Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseDonald P Tashkin, Gary T Ferguson
Respiratory Medicine|February 8, 2018
Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseasesGary T Ferguson, Anthony J Hickey, Sarvajna Dwivedi
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk FactorsGary T Ferguson, Robert Tosiello, Shahin Sanjar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 10, 2013
COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled studyGary T Ferguson, Mo Ghafouri, Luyan Dai, et al.
Cureus|July 10, 2020
Spontaneous Pneumomediastinum/Pneumothorax in Patients With COVID-19Bianka Eperjesiova, Eric Hart, Mohamed Shokr, et al.
Pageof 11